PTHLH and prostate carcinoma: In the bone marrow, tumor-derived PTHrP also promotes recruitment and activation of CD11b+Gr1+ MDSCs, resulting in increased MDSC-derived MMP-9 expression, which drives prostate cancer invasion and angiogenesis.